Instrument Inactif

Autres langues MolMed S.p.A.

Actions

MLM

IT0001080248

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Genenta Science S.p.A. and AGC Biologics S.p.A. Enter into A Development and Manufacturing Services Agreement	01/02/23
AGC Biologics and W.L. Gore & Associates Collaborate on New Protein A-Based Purification Technology and Contract Manufacturing Services for Antibody Therapies	12/12/22
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies	16/08/22
AGC Biologics Partners with BioNTech SE to Further Supply Plasmid DNA Starting Material for the Pfizer-BioNTech COVID-19 vaccine, at AGC’s Heidelberg, Germany facility	07/06/21
MolMed Announces Transition of Luca Alberici from the Role of Chief Business Officer	12/10/20
MolMed S p A : Delisting	30/09/20
MolMed S p A : CS_ integrativo del Comunicato dimissioni consiglieri	06/08/20
MolMed S.p.A.(BIT:MLM) dropped from S&P Global BMI Index	03/08/20
AGC Inc. completed the acquisition of 93.2% in MolMed S.p.A. from Finanziaria d'investimento Fininvest S.p.A. and others for approximately €220 million.	24/07/20
Atlantia : Borsa Milano parte positiva, Atlantia cede oltre 12% su timori revoca	13/07/20
Atlantia : Borsa Milano in rialzo con Stm, auto e banche, deboli lusso e energia	10/07/20
Atlantia : Borsa Milano in rialzo spinta da buoni dati produzione industriale	10/07/20
Atlantia : Borsa Milano poco mossa in avvio, brillano Atlantia, Molmed	10/07/20
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration	09/07/20
AGC : Italy to use vetting powers in Molmed acquisition by Japan's AGC	07/07/20
University of Tartu: Novel DNA analysis will help to identify food origin and counterfeit food in the future	08/06/20
Karolinska Institutet: Overlooked protein could play important part in pneumonia and COVID-19, researchers say	08/05/20
University of Bristol: UK genome analysis has important implications for COVID-19 clinical trials	02/04/20
AGC Inc. entered into an agreement to acquire MolMed S.p.A. from Finanziaria d'investimento Fininvest S.p.A. and others for approximately €240 million.	17/03/20
MolMed S p A : KU awards 38 PhD, 16 M. Phil, two Master of Surgery degrees	12/03/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues MolMed S.p.A.

Actions

MLM

IT0001080248

Autres langues

Filtres